Phase 3 trial of everolimus for metastatic renal cell carcinoma

J. Motzer, Robert; Escudier, Bernard; Oudard, Stephane; E. Hutson, Thomas; Porta, Camillo; Bracarda, Sergio; Grünwald, Viktor; A. Thompson, John; A. Figlin, Robert; Hollaender, Norbert; Kay, Andrea; Ravaud, Alain; the RECORD‐1 Study Group, for

doi:10.1002/cncr.25219

Public

Phase 3 trial of everolimus for metastatic renal cell carcinoma

Shared by NobleBlocks on Jun 14, 2010 • 12:00 AM UTC

Authors:

Robert J. Motzer

Bernard Escudier

Stephane Oudard

Abstract

Abstract BACKGROUND: A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell carcinoma (mRCC) progressing on vascular endothelial growth factor receptor–tyrosine kinase inhibitors. Final results and analysis of prognostic factor...

Discussions